Flupenthixol (fluanxol) in the treatment of psychosomatic disorders in medicine.
D000293:Adolescent; D000328:Adult; D001007:Anxiety / Q000188:drug therapy; D001008:Anxiety Disorders / Q000188:drug therapy; D002749:Chlorprothixene / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003006:Clopenthixol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013892:Thioxanthenes / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D013892:Thioxanthenes; D014149:Tranquilizing Agents; D003006:Clopenthixol; D002749:Chlorprothixene